The Joint Corp (JYNT)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $95.00M
Last updated: Nov 17, 2026 at 11:06 AM ET
The Joint Corp (JYNT) Financials: Revenue, Profit and Cash Flow
The Joint reported revenue of $54.90M for the fiscal year ended Dec 31, 2025, up 5.2% from the year before. That year, net income was $2.91M with a net margin of 5.3%, operating cash flow was $1.84M and free cash flow was $334.72K. The quarter ended Sep 30, 2026 had revenue of $13.55M and net income of -$117.36K.
Revenue and Margins
The operating margin was -1.7% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $20.52M, a compound annual rate of 11.6%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $54.90M | +5.2% | 79.6% | -1.7% | 5.3% |
| Dec 2024 | $52.16M | +11.0% | 77.9% | -3.6% | -11.1% |
| Dec 2023 | $46.98M | -9.9% | 77.7% | 0.7% | -20.8% |
| Dec 2022 | $52.16M | -34.8% | 75.1% | -3.6% | -11.1% |
| Dec 2021 | $80.01M | +36.3% | 90.4% | 7.7% | 9.5% |
| Dec 2020 | $58.68M | +21.1% | 88.9% | 9.4% | 22.4% |
| Dec 2019 | $48.45M | +32.2% | 88.5% | 7.0% | 6.9% |
| Dec 2018 | $36.66M | -26.4% | 88.2% | 0.4% | 0.4% |
| Dec 2017 | $49.84M | +142.8% | 87.1% | -6.7% | -6.9% |
| Dec 2016 | $20.52M | N/A | 85.7% | -73.1% | -73.9% |
Income Statement
In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, the company posted a net loss after a profit in the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $54.90M | $52.16M | $46.98M | $52.16M | $80.01M | $58.68M | $48.45M | $36.66M | $49.84M | $20.52M |
| Cost of revenue | $11.23M | $11.52M | $10.48M | $12.97M | $7.67M | $6.51M | $5.57M | $4.31M | $6.45M | $2.94M |
| Gross profit | $43.67M | $40.65M | $36.50M | $39.19M | $72.35M | $52.18M | $42.88M | $32.35M | $43.39M | $17.58M |
| Operating income | -$913.38K | -$1.89M | $318.30K | -$1.89M | $6.13M | $5.49M | $3.41M | $142.56K | -$3.33M | -$15.01M |
| Net income | $2.91M | -$5.80M | -$9.75M | -$5.80M | $7.57M | $13.17M | $3.32M | $146.70K | -$3.43M | -$15.17M |
| EBITDA | $1.48M | $3.11M | $8.84M | $4.76M | $9.98M | $8.15M | $5.27M | $1.67M | -$1.38M | -$12.44M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.55M | $15.18M | $14.82M | $15.17M | $13.38M | $13.27M | $13.08M | $14.71M | $12.65M | $12.61M | $12.18M | -$40.10M |
| Gross profit | $11.15M | $12.70M | $12.10M | $12.35M | $10.72M | $10.50M | $10.11M | $11.53M | $9.84M | $9.80M | $9.48M | -$42.91M |
| Operating income | $1.33M | -$368.66K | $873.67K | $742.41K | $160.91K | -$1.14M | -$678.53K | $809.72K | -$492.82K | -$1.78M | -$426.60K | $2.24M |
| Net income | -$117.36K | $653.02K | $1.30M | $991.10K | $855.01K | $93.36K | $967.80K | $17.66K | -$3.17M | -$3.60M | $946.98K | -$11.04M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $194.18K by $23.41M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $60.97M | $83.15M | $87.21M | $93.49M | $87.06M | $65.88M | $43.71M | $23.43M | $18.44M | $17.05M |
| Current assets | $52.09M | $74.58M | $44.34M | $17.61M | $26.89M | $25.35M | $13.30M | $11.30M | $6.67M | $5.70M |
| Cash and equivalents | $23.60M | $25.05M | $18.15M | $9.75M | $19.53M | $20.55M | $8.46M | $8.72M | $4.22M | $3.01M |
| Total liabilities | $45.89M | $62.48M | $62.44M | $60.90M | $56.75M | $44.75M | $37.99M | $22.70M | $17.28M | $10.13M |
| Short-term debt | $194.18K | $483.34K | $412.60K | $5.32M | $4.66M | $5.72M | $2.34M | $1.10M | $100.00K | $331.50K |
| Long-term debt | N/A | N/A | $2.00M | $2.00M | $2.00M | $2.00M | $0 | N/A | $1.00M | $0 |
| Shareholder equity | $15.05M | $20.65M | $24.75M | $32.56M | $30.28M | $21.13M | $5.72M | $727.50K | $1.15M | $6.93M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $40.70M | $51.63M | $57.92M | $60.97M | $69.39M | $73.18M | $80.09M | $83.15M | $79.60M | $82.44M | $85.68M | $87.21M |
| Total liabilities | $28.43M | $35.75M | $42.43M | $45.89M | $46.66M | $49.92M | $57.26M | $62.48M | $59.12M | $59.23M | $59.48M | $62.44M |
| Cash and equivalents | $18.30M | $22.16M | $20.68M | $23.60M | $29.70M | $29.81M | $21.92M | $25.05M | $20.74M | $17.46M | $18.74M | $18.15M |
| Shareholder equity | $12.24M | $15.85M | $15.47M | $15.05M | $22.70M | $23.24M | $22.81M | $20.65M | $20.45M | $23.19M | $26.18M | $24.75M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 18.2% of operating cash flow. Share repurchases came to 3378.9% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.84M | $9.42M | $14.68M | $8.21M | $13.84M | $11.18M | $7.52M | $5.45M | -$74.13K | -$10.85M |
| Capital expenditures | $1.50M | $1.19M | $5.00M | $5.90M | $6.99M | $3.16M | $3.48M | $1.11M | $449.20K | $1.57M |
| Free cash flow | $334.72K | $8.23M | $9.68M | $2.31M | $6.85M | $8.03M | $4.04M | $4.34M | -$523.34K | -$12.42M |
| Dividends paid | N/A | N/A | $202.39K | $384.27K | $1.52M | $1.01M | $545.18K | N/A | $0 | $11.42K |
| Share repurchases | $11.31M | $0 | $3.83K | $5.80K | $707.73K | $32.07K | $20.18K | $4.81K | $2.65K | $84.43K |
| Investing cash flow | $6.27M | -$631.55K | -$6.19M | -$17.90M | -$12.75M | -$4.60M | -$7.14M | -$1.24M | -$372.85K | -$2.70M |
| Financing cash flow | -$9.81M | -$2.00M | $174.12K | $328.61K | -$2.00M | $5.60M | -$596.96K | $326.30K | $1.42M | -$239.85K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$128.46K | $2.19M | -$1.48M | $2.90M | $1.77M | $868.65K | -$3.70M | $4.13M | $3.45M | -$973.46K | $2.81M | $3.38M |
| Capital expenditures | $380.17K | $256.26K | $234.60K | $349.40K | $317.84K | $505.04K | $331.50K | $284.25K | $243.94K | $262.40K | $395.05K | $1.17M |
| Free cash flow | -$508.63K | $1.94M | -$1.71M | $2.55M | $1.46M | $363.61K | -$4.03M | $3.85M | $3.20M | -$1.24M | $2.42M | $2.22M |
Frequently Asked Questions About JYNT
What is The Joint's annual revenue?
The Joint reported revenue of $54.90M for the fiscal year ended Dec 31, 2025.
How fast is The Joint's revenue growing?
Revenue was up 5.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 1.7%.
Is The Joint profitable?
Yes. The Joint reported net income of $2.91M for the fiscal year ended Dec 31, 2025, with a net margin of 5.3%.
How much free cash flow does JYNT generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $1.84M minus capital expenditures of $1.50M produced free cash flow of $334.72K.
How much debt does The Joint have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $194.18K and cash and equivalents of $23.60M.
JYNT pages: Overview, Earnings, Forecast, Financials, Valuation